These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Pharmacodynamic aspects of reproterol]. Marmo E Clin Ter; 1981 Sep; 98(5):481-500. PubMed ID: 7307450 [No Abstract] [Full Text] [Related]
28. Mono and bis-6-arylbenzimidazo[1,2-c]quinazolines: a new class of antimicrobial agents. Rohini R; Shanker K; Reddy PM; Ho YP; Ravinder V Eur J Med Chem; 2009 Aug; 44(8):3330-9. PubMed ID: 19371978 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and pharmacological investigation of novel 4-benzyl-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as new class of H1-antihistaminic agents. Alagarsamy V; Solomon VR; Murugan M Bioorg Med Chem; 2007 Jun; 15(12):4009-15. PubMed ID: 17452107 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and pharmacological investigation of novel 4-(2-methylphenyl)-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as new class of H(1)-antihistaminic agents. Alagarsamy V; Rupeshkumar M; Kavitha K; Meena S; Shankar D; Siddiqui AA; Rajesh R Eur J Med Chem; 2008 Nov; 43(11):2331-7. PubMed ID: 18031870 [TBL] [Abstract][Full Text] [Related]
31. Pharmacologic studies on W10,294A, a new bronchodilator. Giles RE; Williams JC; Finkel MP J Pharmacol Exp Ther; 1977 Dec; 203(3):701-11. PubMed ID: 21958 [TBL] [Abstract][Full Text] [Related]
32. Quinazoline and benzimidazole MCH-1R antagonists. Arienzo R; Cramp S; Dyke HJ; Lockey PM; Norman D; Roach AG; Smith P; Wong M; Wren SP Bioorg Med Chem Lett; 2007 Mar; 17(5):1403-7. PubMed ID: 17178222 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and QSAR evaluation of 2-(substituted phenyl)-1H-benzimidazoles and [2-(substituted phenyl)-benzimidazol-1-yl]-pyridin-3-yl-methanones. Sharma D; Narasimhan B; Kumar P; Jalbout A Eur J Med Chem; 2009 Mar; 44(3):1119-27. PubMed ID: 18657885 [TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of novel substituted quinazoline derivatives as antileishmanial agents. Agarwal KC; Sharma V; Shakya N; Gupta S Bioorg Med Chem Lett; 2009 Sep; 19(18):5474-7. PubMed ID: 19692240 [TBL] [Abstract][Full Text] [Related]
35. Relationship between HPLC retention and biological activity of nitrogen-bridged compounds. Shalaby A; Budvári-Bárány Z; Szász G; Hermecz I Acta Pharm Hung; 1985 Nov; 55(6):249-54. PubMed ID: 4083029 [No Abstract] [Full Text] [Related]
37. Synthesis, physicochemical properties and antimicrobial activity of some new benzimidazole derivatives. Ansari KF; Lal C Eur J Med Chem; 2009 Oct; 44(10):4028-33. PubMed ID: 19482384 [TBL] [Abstract][Full Text] [Related]
38. Antiallergic properties of SQ 13,847, an orally effective agent. I. Activity in vivo. Casey FB; Abboa-Offei BE; Marretta J J Pharmacol Exp Ther; 1980 Jun; 213(3):432-6. PubMed ID: 7205610 [TBL] [Abstract][Full Text] [Related]
39. The potentiating effect of an alpha-adrenergic blocking agent (E-643) on the action of bronchodilators. Kitamura S; Ishihara Y; Yotsumoto H; Kosaka K Arzneimittelforschung; 1980; 30(1):37-40. PubMed ID: 6102862 [TBL] [Abstract][Full Text] [Related]
40. Studies on quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides. 8.1, 2 synthesis and pharmacological evaluation of tricyclic fused quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides as potential alpha1-adrenoceptor antagonists. Chern JW; Tao PL; Wang KC; Gutcait A; Liu SW; Yen MH; Chien SL; Rong JK J Med Chem; 1998 Aug; 41(17):3128-41. PubMed ID: 9703460 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]